Decode Health Collaborates with Quest Diagnostics


Collaboration to promote drug and diagnostics R&D in the fields of metabolic disease and autoimmune neurology.

Decode Health has announced a new phase of its collaboration with Quest Diagnostics. In earlier phases of the collaboration, the two parties developed RNA (transcriptome) sequencing capabilities. In this latest phase, the parties have developed a platform for collecting and storing deidentified consented specimens from individuals participating in research.

Read more about the collaboration here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Related Content
© 2024 MJH Life Sciences

All rights reserved.